Helicobacter pylori: The versatile pathogen

Digestive Diseases

Volumn 14, Issue 5, 1996, Pages 289-303

  McGuigan, James E ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cytotoxin; Gastritis; Helicopacter pylori; Lymphoma; Urease

Indexed keywords

ADULT; CHILD; DUODENUM ULCER; DYSPEPSIA; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; REVIEW; STOMACH TUMOR; STOMACH ULCER;

ADULT; CHILD; DUODENAL ULCER; DYSPEPSIA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 0030225545     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000171560     Document Type: Article

References (119)

1. Warren JR: Letter: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i: 1273- 1275.
2. Marshall B: Letter: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983:i: 1273- 1275.
3. Hesscy SJ, Spencer J, Wyatt JL, So-bala G, Rathbone BJ, Axon AT, Dixon MF: Bacterial adhesion and disease activity in Hellcobacter-as-sociated chronic gastritis. Gut 1990; 31:134-138.
4. Dixon MF: Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol 1994:29(suppl 201): 7-10.
5. Mai UEH, Percz-Perez GI, Allen JB, Wahl SM, Blaser MJ, Smith PD: Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992:175:517-525.
6. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E: Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age. race, and socioeconomic status. Gastroenterology 1991:100:1495- 1501.
7. Lee A, Fox JG, Otto G, Dick EH, Krakowka S: Transmission of Helicobacter: A challenge to the dogma of faecal-oral spread. Epidemiol Infect 1991:107:99-109.
8. Mitchell JD, Mitchell HM, Tobias V: Acute Helicobacter pylori infection in an infant, associated with gastric ulceration and serological evidence of intrafamilial transmission. Am J Gastroenterol 1992:87: 382-386.
9. Karttunen R, Andersson G, Poiko-nen K, Kosunen TU, Karttunen T, Juutinen K, Nicmela S: Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol 1990:82:485-488.
10. Sharma SA, Miller GG, Percz-Perez GI, Gupta RS: Humoral and cellular immune recognition o(Helicobacter pylori proteins are not concordant. Clin Exp Immunol 1994:97:126- 132.
11. Siurala M, Varis K, Wiljasalo M: Studies of patients with artrophie gastritis: A 10-15 year follow-up. Scand J Gastroenterol 1966.1:40-48.
12. Kimura K: Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972;63: 584-592.
13. Siurala M, Sipponen P, Kekki M: Campylobacter pylori in a sample of Finnish population: Relation to morphology and functions of the gastric mucosa. Gut 1988:29:909-914.
14. Correa P, Haenszel W, Cucllo E, et al: Gastric precancerous process in a high risk population: Cohort follow-up. Cancer Res 1990:50:4737- 4740.
15. Leunk RD, Johnson PT, David BC, et al: Cytotoxic activity in broth culture filtrates of Campylobacter pylori. J Med Microbiol 1988:26:414-417.
16. Kawano S, Tsujii M, Fusatnoto H, Sato N, Kamada T: Chronic effect of intragastric ammonia on gastric mucosal structures in rats. Dig Dis Sci 1991;36:33-38.
17. Marshall BJ: Virulenceand pathogenicity of Helicobacter pylori. J Gastroenterol Hepatol 1991;6:121-124.
18. Ncgrini R, Lisato L, Zanella I, et al: Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991;101:437-445.
19. Salmcla KS, Roine RP, Koivisko T, et al: Characteristics of Helicobacter pylori alcohol dehydrogenase. Gastroenterology 1993;105:325-330.
20. Lee A, Fox J, Hazell S: Pathogenicity of Helicobacter pylori: A perspective. Infect Immun 1993:61:1601-1610.
21. Lichtenbcrger LM, Dial EJ, Romero JJ, Lechago J, Jarboe LA, Wolfe MM: Role of luminal ammonia in the development of gastropathy and hypcrgastrinemia in the rat. Gastroenterology 1995;108:320-329.
22. Evans DJ, Evans DG, Engstrand L, Graham DY: Urease-associated heat-shock protein of Helicobacter pylori. Infect Immun 1992:60: 2125-2127.
23. Dunn BE, Roop RM, Sung CC, Sharma SA, Perez-Pcrez GI, Blaser MJ: Identification of a cpn60 heat-shock protein homolog from Helicobacter pylori. Infect Immun 1992; 60:1946-1951.
24. Wyatt JL, Rathbone BJ, Dixon MF, Heatley RV: Campylobacter pylori-tis and acid-induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987:40:841-848.
25. Wyatt JI, Rathbone BJ, Sobala G, et al: The prevalence and distribution of gastric epithelium in the duodenum and its relationship to Helicobacter pylori and inflammation. J Clin Pathol 1990;43:981-986.
26. Hemalatha SG, Drumm B, Sherman P: Adherence of Helicobacter pylori to human gastric epithelial cells in vitro. J Med Microbiol 1991:35: 197-202.
27. Smoot DT, Resau JH, Naab T, et al: Adherence of Helicobacter pylori to cultured human gastric epithelial cells. Infect Immun 1993:61:350-355.
28. Boren R, Falk P, Roth KA, Larson G, Normark S: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993,262:1892- 1895.
29. Cover RL, Dooley CP, Blaser MJ: Characterization and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cvtotoxin activity. Infect Immun 1990:58:603- 610.
30. Crabtree JE, Taylor JD, Wyatt JL, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ: Mucosal IgA recognition of Helicobacter pylori 120 kD protein, peptic ulceration, and gastric pathology. Lancet 1991: 338:332-335.
31. Tummuru MKR, Cover TL, Blaser MJ: Cloning and expression of a high molecular weight major antigen of Helicobacter pylori: Evidence of linkage to cytoloxin production. Infect Immun 1993:61:1799-1809.
32. Perez-Perez GI, Dworkin BM, Cho-dos JE, Blaser MJ: Campylobacter pylori antibodies in humans. Ann Intern Med 1988;109:11-17.
33. Cover TL, Blaser MJ: Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992:267:1570-1575.
34. Cover TL, Blaser MJ: Purification and characterization of the vacuolating toxin from Helicobacter pylori. I Biol Chem 1992:267:10570-10575.
35. Ricci V, Sommi P, Cova E, Fiocca R, Romano M, Ivey KJ, Solcia E, Ventura U: NaLK’-ATPase of gastric cells: A target of Helicobacter pylori cytotoxic activity. FEBS Lett 1993;334:158-160.
36. Mac Knight ADC, Leaf A: Regulation of cellular volume. Physiol Rev 1977;57:510-573.
37. Fiocca R, Villani L, Turpini F, Tur-pini R, Solcia E: High incidence of Campylobacter-like organisms in endoscopic biopsies from patients with gastritis with or without peptic ulcer. Digestion 1987:38:234-244.
38. Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley LJ, Rappuoli R: Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA-positive phenotype. J Clin Pathol 1995:48: 41-45.
39. Pcrcz-Pcrcz GI, Shepherd VL, Morrow JD, Blaser MJ: Activation of human THP-I cells and rat bone marrow-derived macrophages by Helicobacter pylori I ipopolysaccharide. Infect Immun 1995:63:1183- 1187.
40. Kaihovaara P, Salmeta KS, Roine RP, Kosunen TU, Salaspuro M: Purification and characterization of Helicobacter pylori alcohol dehydrogenase. Alcohol Clin Exp Res 1994: 18:1220-1225.
41. Blaser MJ, Parsonnet J: Parasitism by the ‘slow’ bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8.
42. Hazcll S: Urease and catalasc as virulence factors of Helicobacter pylori; in Menge H. Gregor M, Tytgat GNJ, Marshall BJ, McNulty CAM (eds): Helicobacter pylori 1990. Berlin. Springer. 1991, pp 3-9.
43. Hazcll SL, Evans DJ, Graham DY: Helicobacter pylori catalase. J Gen Microbiol 1991:137:57-61.
44. Smith AW, Chahal B, French GL: The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinasc in Vibrio cholerae. Mol Microbiol 1994:13:153-160.
45. Markesich DC, Anand BS, Lew GM, Graham DY: Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel. Gut 1995:36:327-329.
46. Exner MM, Doig P, Trust TJ, Hancock RE: Isolation and characterization of a family of porin proteins from Helicobacter pylori. Infect Immun 1995;63:1567-1572.
47. Craig PM, Territo MC, Karnes WE, Walsh JH: Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 1992:33:1020-1023.
48. Nielsen H, Andersen LP: Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes and monocytes. Gut 1992:33:738-742.
49. Crabtree JE, Rathbonc BJ, Heatley RV, Wyatt JI, Losow'sky MS: In vitro glycoprotein synthesis and secretion in Campylobacter pylondis-as-sociatcd chronic gastritis. Proc Fourth International Workshop of Campylobacter Infections, Göteborg 1987. abstr 38.
50. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI: Mucosal tumour necrosis factor-a and interleukin-6 in patients with Helicobacterpylori-as-sociated gastritis. Gut 1991:32: 1473-1477.
51. Moss S, Calam J: Helicobacter pylori and peptic ulcers: The present position. Gut 1992;33:289-292.
52. Peek RM Jr, Blaser MJ, Miller GG: cagA-positive Helicobacter pylori strains induce preferential cytokine expression in gastric mucosa. Gastroenterology 1994; 106: A158.
53. Crowe SE, Alvarez L, Dytoc M, Hunt RH, Muller M, Sherman P, Patel J, Jin Y, Emst PR: Expression of interleukin-8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 1995;108:65-74.
54. Ramsey EJ, Peterson WL, Carey KV, Jackson JJ, Murphy FK, Read NW, Taylor KB, Trier JS, Fordtran JS: Epidemic gastritis with hypo-chlorhydria. Gastroenterology 1979; 76:1449-1457.
55. Graham DY, Alpert LC, Smith JL, Yoshimura HH: Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988:83:974-980.
56. Morris A, Nicholson G: Experimental and accidental C. pylori infection of humans; in Blaser MJ (ed): Campylobacter pylori in Gastritis and Peptic Ulcer Disease. New York. Igaku Shoin. 1989. pp 73-97.
57. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J: Campylobacter pylori and duodenal ulcers: The gastrin link. Lancet 1989;i:1167-1168.
58. Smith JTL, Pounder RE, Evans DJ, Graham DY, Evans DG: Inappropriate 24hour hypergastrinemia in asymptomatic C. pylori infection. Gut 1989;30:A732-A733.
59. Graham DY, Opekun A, Lew GM, Evans DJ Jr, Klein PD, Evans DG: Ablation of exaggerated mcal-stimu-latcd gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990: 85:394-398.
60. Karnes WE, Ohning GV, Sytnik B, Kim SWR, Walsh JH: Preservation of pH inhibition of gastrin release in subjects with Helicobacter pylori. Rev Infect Dis 1991; 13:S665-S670.
61. El-Omar E, Penman I, Dorrian CA, Ardill JES, McColl KEL: Eradicating Helicobacter pylori infection lowers gastrin-mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993:34:1060- 1065.
62. Beil W, Birkholz C, Wagner S, Sewing KF: Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric 117K(*)-ATPASE. Gul 1994:35:1176-1180.
63. Tarnasky PR, Kovacs TOG, Sytnik B, Walsh JH: Asymptomatic II pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation. Dig Dis Sci 1993:38:1681-1687.
64. McGuigan JE, Trudeau WL: Differences in rates of gastrin release in normal individuals and patients with duodenal ulcer. N Engl J Med 1973:288:64-66.
65. McGuigan JE, Harty RF, Maico DG: The role of gastrin in duodenal ulcer. Trans Am Clin Climatol Assoc 1980:92:199-207.
66. Harty RF, Maico DG, McGuigan JE: Antral release of gastrin and somatostatin in duodenal ulcer and control subjects. Gut 1986:27:652-658.
67. Trudeau WL, McGuigan JE: Relations between serum gastrin levels and rates of gastric hydrochloric acid secretion. N Engl J Med 1971; 284:408-412.
68. Tsujii M, Kawano S, Tsuji S, Takci Y, Tamura K, Fusamoto H, Ka-mada T: Mechanism for ammonia-induced promotion of gastric carcinogenesis in rats. Carcinogenesis 1995:16:563-566.
69. Mitchell HM, Li YY, Hu PJ, Liu Q, Chen M, Du GG, Wang ZJ, Lee A, Hazell SL: Epidemiology of Helicobacter pylori in Southern China -Identification of early childhood as the critical period for acquisition. J Infect Dis 1992;166:149-153.
70. Megraud F, Brassens-Rabbe MP, Denis F, Bclbouri A, Hoa DQ: Sc-roepidcmiology of Campylobacter pylori infection in various populations. J Clin Microbiol 1989:27: 1870-1873.
71. Tytgal GNJ: Helicobacter pylori: Recent developments. J Gastroenterol 1994:29(suppl Vll):30-33.
72. Khutusi S, Mendall MA, Badve S, Patel P, Finlayson C, Northficld TC: Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut 1995:36:193-197.
73. Isenberg JI, Selling JA, Hogan DL, Koss MA: Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer. N Engl J Med 1987;316:374-379.
74. Rapier RD, Drcilinger AD, Nybcrg LM, Koss MA, Hogan DL, Isenberg JI: Helicobacter pylori diminishes proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer disease. Gastroenterology 1994:106: A164.
75. Walsh JH, Richardson CT, Ford-tran JS: pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 1975;55:462-468.
76. McColl KEL, Fullarton GM, Nuju-mi EL, MacDonald AM: Cowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer. Lancet 1989:ii:499-500.
77. Peterson WL, Barnett CC, Evans DJ, et al: Acid secretion and plasma gastrin in normal subjects and patients with duodenal ulcer: The role of Helicobacter pylori. Am J Gastroenterol 1993:88:2038-2043.
78. Metz DC, Weber HC, Orbuch M, Strader DB, Jensen RT: Helicobacter pylori infection. A reversible cause of hypergastrinemia and hv-perchlorhydria which may mimic Zollingcr-Ellison syndrome. Dig Dis Sci 1995;40:153-159.
79. Coghlan JG, Gilligan D, Humphries H, et al: Campylobacter pylori and recurrence of duodenal ulcers - A 12-month follow-up study. Lancet 1987:ii:1109-1111.
80. George LL, Bordy TJ, Andrews P, et al: C ure of duodenal ulcer after eradication of Helicobacter pylori. Med J Ausl 1990;153:145-149.
81. O’Connor HJ: Eradication of Helicobacter pylori: Therapies and clinical implications. Postgrad Med J 1992;68:549-557.
82. Labenz J, Gyenes E, Ruhl GH, Borsch G: HP reinfection and clinical course of ulcer disease in the first year after amoxicillin omeprazole treatment. Ir J Med Sci 1992; 16 (suppl 10): 15.
83. Hcnlschcl E, Brandstaltcr G, Drago-sics B, et al: ElTcct of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993:328:308-312.
84. Tytgat GNJ: Long-term consequences of Helicobacter pylori crad i-cation. Scand J Gastroenterol 1994; 29(suppl 205):38-44.
85. Dixon MF, Sobala GM: Gastritis and duodenitis: The histopatholog-ical spectrum. Eur J Gastroenterol Hepatol 1992:4(suppl 2): 17-23.
86. Craanen ME, Dekker W, Blok P, Ferweda J, Tytgat GNJ: Intestinal metaplasia and Helicobacter pylori: An endoscopic biopsy study of the gastric antrum. Gut 1992:33:16-20.
87. Isaacson PG, Spencer J: Malignant lymphoma of mucosa-associated lymphoid tissue: A distinctive type of B lymphoma. Cancer 1983:52: 1410-1416.
88. Isaacson PG: Lymphomas of mucosa-associated lymphoid tissue. His-topathology 1990:16:617-619.
89. Wothcrspoon AC, Pan LX, Diss TC, Isaacson PG: Cytogenetic study of B-ecll lymphoma of mucosa-associated lymphoid tissue. Cancer Genet Cytogenet 1992;58:35-38.
90. Rubin E, Arber JL: The gastrointestinal tract: in Rubin E. Färber JL (eds): Essential Pathology. Philadelphia. Lippincott. 1990. pp 352- 392.
91. Kirchner T, Melber A, Fischbach W, Hcilmann KL, Mullcr-Hcrme-link HK: lmmunohistochemical patterns of the local immune response in Helicobacter pylori gastritis: in Malfertheimer P. Dischuneit I I (eds): Helicobacter pylori. Gastritis and Peptic Ulcer. Berlin. Springer, 1990. pp 213-222.
92. Hussell T, Isaacson PG, Crabtree JE, Spencer J: The response of cells from low-grade B-cell gastric lymphomas of mucosa-associatcd lymphoid tissue to Helicobacter pylori. Lancet 1993:342:571-574.
93. Greiner A, Marx A, Hecscmann J, Leebmann J, Schmaubcr B, Muller-Hermelink HK: Idiotypc identity in a MALT-type lymphoma and B cells in Helicobacter pylori-associated chronic gastritis. Lab Invest 1994; 70:572-578.
94. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG: Regression of primary low-grade B-ccll gastric lymphoma of mucosa-associated lymphoid t issue type after eradication of Helicobacter pylori. Lancet 1993:342:575-577.
95. Roggcro E, Zucca E, Pinotti G, Pascarclla A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F: Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995:122: 767-769.
96. Ishido T, Mori N, Kikuchi M, Nakamura K: Primary gastric malignant lymphoma: A morphological and immunohistochcmical study of 38 cases. Acta Pathol Jpn 1989: 39:229-234.
97. Villar HV, Wong R, Paz B, et al: Immunophenotvping in the management of gastric lymphoma. Am J Surg 1991,161:171-175.
98. Lcc JD, Ko YH, Park JH, Min KR, Park KN: Histological and immu-nohistochemical studies on primary gastrointestinal lymphomas. J Korean MedSci 1993:8:17-23.
99. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Wamke RA, Jellum E, Orentreich N, Vogclman JH, Friedman GD: Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994:330:1267-1271.
100. Forman D, Webb P, Newell D, Coleman M, Palli D, Moller H, Hcngels K, Elder J, De Backer G: An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341:1359-1362.
101. De Koster E, Buset M, Fernandes E, Deltenre M: Helicobacter pylori: The link with gastric cancer. Fur J Cancer Prev 1994:3:247-257.
102. Correa P, Fox J, Fontham E, Ruiz B, Lin YP, Zavala D, Taylor N, Mackinley D, de Lima E, Portilla H, Zarama G: Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990:66:2569-2574.
103. The Gastrointestinal Physiology Working Group: Helicobacter pylori and gastritis in Peruvian patients: Relationship to socioeconomic level, age, and sex. Am J Gastroenterol 1990:85:819-823.
104. Sipponen P, Kosuncn TU, Valle J, Riihla M, Seppala K: Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992:45:319-323.
105. Munoz N, Correa P, Cucllo C, Duque E: Histologic types of gastric carcinoma in high- and low-risk areas. Int J Cancer 1968:3: 809-818.
106. Munoz N, Connelly R: Time trends of intestinal and diffuse types of gastric cancer in the United States. Int J Cancer 1971:8: 158-164.
107. Howson CP, Hiyama T, Wyndcr EL: The decline in gastric cancer: Epidemiology of an unexplained triumph. Epidemiol Rev 1986:8: 1-27.
108. Parsonnet J, Friedman GD, Van-dcrstecn DP, et al: Helicobacter pylori infection and the risk of gastric cancer. N Engl J Med 1991:325: 1127-1131.
109. Nomura A, Stemmermann GN, Chyou BH, Kato I, Perez-Percz G, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991:325: 1132-1136.
110. Buruk F, Berberoglu U, Pak I, Ak-saz E, Cclen O: Gastric cancer and Helicobacter pylori infection. Br J Surg 1993:80:378-379.
111. Endo S, Ohkusa T, Saito TY, Fuji-ki K, Okavasu I, Sato C: Detection of Helicobacter pylon infection in early stage gastric cancer: A comparison between intestinal and diffuse type gastric adenocarcinomas. Cancer 1995:75:2203-2208.
112. Tatsuta M, Iishi H, Okuda S, Tani-guchi IT, Yokota Y: The association of Helicobacter pylori with dif-fcrentiated-tvpe early gastric cancer. Cancer 1993:72:1841-1845.
113. Sipponen P: Gastric cancer - A long-term consequence of Helicobacter pylori infection? Scand.1 Gastroenterol 1994;29(suppl 201): 24-27.
114. Brcnes F, Ruiz B, Correa P, et al: Helicobacter pylori causes hvper-proliferation of the gastric epithelium: Prc- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993; 88:1870-1875.
115. Vollmers HP, Dammrich J, Rib-bert H, Grassel S, Debus S, Heesc-niann J, Mullcr-Hcrmelink HK: Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro. Cancer 1994:74:1525-1532.
116. Parsonnet J, Friedman GD, Van-dersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991:325:1127-1131.
117. Munoz N: Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol Biomarkers Prev 1994;3:445-451.
118. McCarthy C, Patchen S, Collins RM, Beattie S, Keane C, O'Marain C: Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sei 1995:40: 114-119.
119. Schlempcr RJ, van der Werf SD, Vandenbrouckc JP, Bicmond T, Lamers CB: Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association. Arch Intern Med 1995:155:82-87.